Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Eye (London, England)|November 20, 2002
Biometry of the silicone oil-filled eye: IID C Murray, O M Durrani, P Good, et al.Australasian Physical & Engineering Sciences in Medicine|September 1, 1990
The production of body analogs for use in radiation physicsP E Metcalfe, P W Hoban, N R Harper, et al.Medical Physics|May 1, 1991
Superposition on a multicomputer systemD C Murray, P W Hoban, W H Round, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996
Outcome and risk factors for left ventricular disorders in chronic uraemiaP S Parfrey, R N Foley, J D Harnett, et al.Kidney International|December 9, 1998
Long-term evolution of cardiomyopathy in dialysis patientsR N Foley, P S Parfrey, G M Kent, et al.Journal of the American Society of Nephrology : JASN|May 1, 1996
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.Kidney International|May 1, 1996
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.Journal of the American Society of Nephrology : JASN|June 1, 1995
The prognostic importance of left ventricular geometry in uremic cardiomyopathyR N Foley, P S Parfrey, J D Harnett, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.Journal of the American Society of Nephrology : JASN|April 4, 1998
Mode of dialysis therapy and mortality in end-stage renal diseaseR N Foley, P S Parfrey, J D Harnett, et al.Pageof 3